Wow,the Web is getting bigger,alot of possibilities alot going on,titan should just license out and get royaltis from all,a cash cow,at least before they scoop them up.Doc,see any articles of interest out there.
IMHO Alkermes can't doddle and lose competitive advantage to an implantable antagonist.. Vivitrol is their flagship.. they may act sooner rather than later to protect their franchise
News 
Market Data 
Discover 
AI
